Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for paracrine activities in bone regeneration

Biochemical and Biophysical Research Communications

Volumn 426, Issue 4, 2012, Pages 475-479

  Li, Feng ^a   Whyte, Noelle ^a   Niyibizi, Christopher ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Bone morphogenetic protein 2; Bone regeneration; Mesenchymal stem cells; Mesenchymal stem cells and paracrine activities

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; CYTOKINE ANTIBODY; NEUTRALIZING ANTIBODY; OSTEOCALCIN; PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME REPRESSION; FEMUR; GENE EXPRESSION REGULATION; IN VIVO STUDY; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOVEMENT; FLOW CYTOMETRY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MULTIPOTENT STEM CELLS; OSTEOGENESIS; PARACRINE COMMUNICATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE; MUS;

EID: 84867218797     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.095     Document Type: Article

References (19)

1. Jethva R., Otsuru S., Dominici M., Horwitz E.M. Cell therapy for disorders of bone. Cytotherapy 2009, 11:3-17.
2. Niyibizi C., Li F. Potential implications of cell therapy for osteogenesis imperfecta. Int. J. Clin. Rheumtol. 2009, 4:57-66.
3. Evans C.H., Liu F.J., Glatt V., Hoyland J.A., Kirker-Head C., Walsh A., Betz O., Wells J.W., Betz V., Porter R.M., Saad F.A., Gerstenfeld L.C., Einhorn T.A., Harris M.B., Vrahas M.S. Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. Eur. Cell. Mater. 2009, 18:96-111.
4. Lien C.Y., Chih-Yuan Ho K., Lee O.K., Blunn G.W., Su Y. Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. J. Bone Miner. Res. 2009, 24:837-848.
5. Guillot P.V., Abass O., Bassett J.H., Shefelbine S.J., Bou-Gharios G., Chan J., Kurata H., Williams G.R., Polak J., Fisk N.M. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 2008, 111:1717-1725.
6. Panaroni C., Gioia R., Lupi A., Besio R., Goldstein S.A., Kreider J., Leikin S., Vera J.C., Mertz E.L., Perilli E., Baruffaldi F., Villa I., Farina A., Casasco M., Cetta G., Rossi A., Frattini A., Marini J.C., Vezzoni P., Forlino A. In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knock in murine model for classical, dominant osteogenesis imperfecta. Blood 2009, 114:459-468.
7. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., Koo W.W., Gordon P.L., Neel M., Sussman M., Orchard P., Marx J.C., Pyeritz R.E., Brenner M.K. Transplant ability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 1999, 5:309-313.
8. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., Muul L., Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. USA 2002, 99:8932-8937.
9. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 2008, 103:1204-1219.
10. Li F., Wang X., Niyibizi C. Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. Bone 2010, 47:546-555.
11. Niyibizi C., Wang S., Mi Z., Robbins P.D. The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice. Implications for skeletal gene therapy via stem cells. Mol. Ther. 2004, 9:955-963.
12. Gambotto A., Dworacki G., Cicinnati V., Kenniston T., Steitz J., Tuting T., Robbins P.D., DeLeo A.B. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice. Identification of an H2-Kd-restricted CTL epitope. Gene Ther. 2000, 7:2036-2040.
13. Li F., Wang X., Niyibizi C. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Stem Cells 2007, 25:3183-3193.
14. Ek E.T., Dass C.R., Contreras K.G., Choong P.F. Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor. Clin. Exp. Metastasis. 2007, 24:93-106.
15. Tombran-Tink J., Barnstable C.J. Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: possible mediators of angiogenesis and matrix remodeling in the bone. Biochem. Biophys. Res. Commun. 2004, 316:573-579.
16. Venturi G., Gandini A., Monti E., Dalle Carbonare L., Corradi M., Vincenzi M., Valenti M.T., Valli M., Pelilli E., Boner A., Mottes M., Antoniazzi F. Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen. J. Bone Miner. Res. 2012, 27:723-728.
17. Homan E.P., Rauch F., Grafe I., Lietman C., Doll J.A., Dawson B., Bertin T., Napierala D., Morello R., Gibbs R., White L., Miki R., Cohn D.H., Crawford S., Travers R., Glorieux F.H., Lee B. Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J. Bone Miner. Res. 2011, 26:2798-2803.
18. Hoeben A., Landuyt B., Highley M.S., Wildiers H., Van Oosterom A.T., De Bruijn E.A. Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 2004, 56:549-580.
19. Lapidot T., Dar A., Kollet O. How do stem cells find their way home?. Blood 2005, 106:1901-1910.